what now?, page-19

Absolutely agree - just looking at the chart and revised earnings you can see how ridiculous the sell off has been.

Interesting reading through all the broker reports over the past 2 weeks since earnings revision....JP Morgan, Macquarie, Merrill Lynch & RBS are all still overweight/outperform although 12 month price targets are now in the $12-$13 range. It is just the clowns at Credit Suisse who don't seem to know what they are doing - when the earnings downgrade came out they actually lifted the rating to neutral from underperform (price target $11.30 from $11.90), then a few days later said they don't really know and then on the 24th after Monsanto news they downgraded back to underperform and $10.20 price target.

So even on the most pessimistic broker update we are over 10% below but that seems to be very much an outlier out of the overall broker coverage.

Having said all that, if the SP does not trade up today you really have to wonder what is going on - positive lead from US/Monsanto, how long do disgruntled investors sell down the stock at a significant loss? Not terribly rational thinking IMO.